Life Sciences Forum
The Sizzling Science and Business of Immuno-Oncology
What is the immuno-oncology revolution that’s sweeping the world of cancer treatments? How is it impacting every aspect of cancer treatment development for companies (small and large), clinicians, payers and patients?
Come hear from panelists who are living at the pioneering intersection of science and business of immuno-oncology. Ask your tough questions about the field and its potential to provide cures to certain cancers.
Panelists:
- Mark Velleca, MD, Ph.D., chief executive officer, G1 Therapeutics
- Smita Nair, Ph.D., associate professor of surgery, Duke University School of Medicine, director of immunotherapy sciences focus group, Duke Cancer Institute
- Taylor Schreiber, M.D., Ph.D., chief scientific officer, Heat Biologics
- Bruce McCreedy, Ph.D., senior vice president cell therapy, Precision BioSciences
Moderator:
- Anil Goyal, Ph.D., CLP, managing director, OpenDoors Group, vp of business development at Esanex, Inc and MimiVax, LLC
Presented by NC COIN and NCBiotech Center
Agenda
4 p.m. - Registration
4:30 p.m. - Program
6 p.m. - Reception and networking
Registration
Tickets are $25 advance/$30 on-site
-
North Carolina Biotechnology Center
$25 advance/$30 on-site